Log In
Sign Up
Hormone receptor positive, HER2 / neu negative advanced breast cancer [in combination with exemestane]; neuroendocrine tumours of pancreatic origin; renal cell carcinoma.
10mg OD [to continue treatment as long as clinical benefit is observed or until remarkable toxicity occurs]. If the dose is reduced, it must not be lower than 5mg OD.
Mode of action
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Afinitor. tabs 10mg 30 KES156,350.00
Certican. tabs 0.5mg 60 KES17,400.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us